Study Reference No. C1C02612

Study Type Demographic Gender Age Location Compensation
Healthy; females with non-childbearing potential Post-menopausal or surgically sterile females (documentation from medical provider of surgical sterile status required); Non-smokers or smokers (smoking <10 cigarettes / day) Females 18 to 65 years Saint Petersburg FL $2,500
Study Details

Study Objective

The purpose of this study is to see if an investigational drug (new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)) is bioequivalent. Bioequivalent means the active study drug is absorbed into the body at the same rate and amount as an already approved currently marketed drug.

Study Duration

The duration of your participation will be up to 19 cliays not including the screening period. The study includes a medical screening and 2 periods with two overnight stays (in each period 1 and 2) which starts 36 hours prior to Day 1 (dosing) and lasts for up to 24 hours after dosing. There are a total of 4 return visits per period which are at 48, 72, 96 and 120 hours after dosing of study drug.

Study Schedule

General Screening


Medical Screening

Contact recruitment

Study Visit(s)

Contact recruitment.

Follow-Up Visit(s)


Other Notes

Bring Valid Photo ID.

Study eligible for referral program. Ask us for details.